Ambea closes Humana offer with 97.99% acceptance

• Ambea closed its Humana offer on October 14, 2026, with acceptances for 46,564,851 shares, representing approximately 97.99%.
• The offer comprised SEK 20 cash, 0.305 Ambea shares and one CVR Instrument per Humana share.
• Compulsory redemption proceedings have begun for remaining shares; Humana's last trading day on Nasdaq Stockholm is October 27, 2026.
• Settlement for shares tendered during the extended acceptance period is expected to begin around October 21, 2026.
• A new issue of 1,036,436 shares will deliver the extended-period share consideration, resulting in approximately 1.2% dilution.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ambea AB published the original content used to generate this news brief via Cision (Ref. ID: 20261015:BIT:4063:0) on October 15, 2026, and is solely responsible for the information contained therein.